Richard Ranieri
Direttore/Membro del Consiglio presso XENCOR, INC.
Patrimonio netto: 261 194 $ in data 31/05/2024
Profilo
Richard J.
Ranieri currently works at Xencor, Inc., as Independent Director from 2017.
Mr. Ranieri also formerly worked at Sumitomo Pharma America, Inc., as EVP-Human Resources & Administration from 2008 to 2011, Neurocrine Biosciences, Inc., as Chief Administrative Officer & SVP-Human Resources in 2008, BioMarin Pharmaceutical, Inc., as Senior VP-Human Resources & Corporate Affairs from 2013 to 2019, Dendreon Corp., as Executive Vice President-Human Resources from 2011 to 2013, Genencor International, Inc., as Senior Vice President-Human Resources from 1993 to 2005, and GlaxoSmithKline LLC, as Principal.
Mr. Ranieri received his graduate degree from Rider University and undergraduate degree from Villanova University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
XENCOR, INC.
0.02% | 13/06/2024 | 10 993 ( 0.02% ) | 261 194 $ | 31/05/2024 |
Posizioni attive di Richard Ranieri
| Società | Posizione | Inizio |
|---|---|---|
| XENCOR, INC. | Direttore/Membro del Consiglio | 19/12/2017 |
Precedenti posizioni note di Richard Ranieri
| Società | Posizione | Fine |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Ufficiale delle Risorse Umane | 01/01/2019 |
| DENDREON CORPORATION | Ufficiale delle Risorse Umane | 01/01/2013 |
| NEUROCRINE BIOSCIENCES, INC. | Direttore Amministrativo | 01/08/2008 |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Ufficiale delle Risorse Umane | 01/01/2005 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Formazione di Richard Ranieri
| Villanova University | Undergraduate Degree |
| Rider University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Richard Ranieri
